Evidence map›Paper›PMID 26831109›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation.

Samantha P Harris, Betty Belknap, Robert E Van Sciver, Howard D White, Vitold E Galkin

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structure of mavacamten-free human cardiac thick filaments within the sarcomere by cryoelectron tomography.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Hypertrophic cardiomyopathy inThe journal of cardiovascular aging · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. In situ FRET-based localization of the N terminus of myosin binding protein-C in heart muscle cells.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Samantha P HarrisDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724;
Betty BelknapDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA 23507.
Robert E Van SciverDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA 23507.
Howard D WhiteDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA 23507.
Vitold E GalkinDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA 23507 galkinve@evms.edu.
Eastern Virginia Medical School · USUniversity of Arizona · US

Funding

Role of Myosin Binding Protein-C in the Regulation of Myocardial ContractionR01HL080367 · NHLBI · UNIVERSITY OF WASHINGTON · PI Samantha P Harris · 2005 to 2026
$7.5M
NHLBI NIH HHS R01 HL080367
6 · The paper itself

Abstract

Mutations in genes encoding myosin, the molecular motor that powers cardiac muscle contraction, and its accessory protein, cardiac myosin binding protein C (cMyBP-C), are the two most common causes of hypertrophic cardiomyopathy (HCM). Recent studies established that the N-terminal domains (NTDs) of cMyBP-C (e.g., C0, C1, M, and C2) can bind to and activate or inhibit the thin filament (TF). However, the molecular mechanism(s) by which NTDs modulate interaction of myosin with the TF remains unknown and the contribution of each individual NTD to TF activation/inhibition is unclear. Here we used an integrated structure-function approach using cryoelectron microscopy, biochemical kinetics, and force measurements to reveal how the first two Ig-like domains of cMyPB-C (C0 and C1) interact with the TF. Results demonstrate that despite being structural homologs, C0 and C1 exhibit different patterns of binding on the surface of F-actin. Importantly, C1 but not C0 binds in a position to activate the TF by shifting tropomyosin (Tm) to the "open" structural state. We further show that C1 directly interacts with Tm and traps Tm in the open position on the surface of F-actin. Both C0 and C1 compete with myosin subfragment 1 for binding to F-actin and effectively inhibit actomyosin interactions when present at high ratios of NTDs to F-actin. Finally, we show that in contracting sarcomeres, the activating effect of C1 is apparent only once low levels of Ca(2+) have been achieved. We suggest that Ca(2+) modulates the interaction of cMyBP-C with the TF in the sarcomere.

Indexed as

Actin CytoskeletonActinsAdenosine TriphosphatasesAdenosine TriphosphateAnimalsCalciumCarrier ProteinsCell Membrane PermeabilityHumansHydrolysisModels, MolecularMuscle CellsMuscle ContractionMyosin Binding Protein CMyosin SubfragmentsProtein BindingActinsAdenosine TriphosphatasesAdenosine TriphosphateCalciumCarrier ProteinsMyosin Binding Protein CMyosin Subfragmentsactincryo-EMmuscle regulationmyosin binding protein Ctropomyosin

Identifiers

PMID26831109
PMCPMC4760775
OpenAlexW2253556870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.